MTHFR 677TT genotype and toxicity of methotrexate: Controversial results

Cancer Chemotherapy and Pharmacology

Volumn 68, Issue 5, 2011, Pages 1369-1370

  Lopez–Lopez, Elixabet ^a   Ballesteros, Javier ^a   Garcia Orad, Africa ^a  

^a UNIVERSITY OF THE BASQUE COUNTRY UPV EHU   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

METHOTREXATE;

ACUTE LYMPHOBLASTIC LEUKEMIA; BLOOD TOXICITY; DRUG DOSE COMPARISON; GENE; GENETIC ASSOCIATION; GENETIC POLYMORPHISM; GENETIC RISK; GENETIC VARIABILITY; GENOTYPE; HOMOZYGOTE; HUMAN; METHYLENETETRAHYDROFOLATE REDUCTASE GENE; PHARMACOGENETICS; PRIORITY JOURNAL; REVIEW;

EID: 82455210917     PISSN: 03445704     EISSN: 14320843     Source Type: Journal    
DOI: 10.1007/s00280-011-1719-4     Document Type: Review

References (15)

1. D'Angelo V, Ramaglia M, Ianotta A, Crisci S et al (2011) Methotrexate toxicity and efficacy during the consolidation phase in paediatric acute lymphoblastic leukaemia and MTHFR polymorphisms as pharmacogenetic determinants. Cancer Chemother Pharmacol. doi: 10.1007/s00280-011-1665-1 (Published on line on 18 May 2011)
2. N Shimasaki T Mori H Samejima R Sato, et al. 2006 Effects of methylenetetrahydrofolate reductase and reduced folate carrier 1 polymorphisms on high-dose methotrexate-induced toxicities in children with acute lymphoblastic leukemia or lymphoma J Pediatr Hematol Oncol 28 2 64 68 16462575 10.1097/01.mph.0000198269.61948.90 1:CAS:528:DC%2BD28XisF2qs7k%3D
3. M Horinouchi M Yagi H Imanishi T Mori, et al. 2010 Association of genetic polymorphisms with hepatotoxicity in patients with childhood acute lymphoblastic leukemia or lymphoma Pediatr Hematol Oncol 27 5 344 354 20670164 10.3109/08880011003739422 1:CAS:528:DC%2BC3cXpsFSktLc%3D
4. NV Karathanasis E Stiakaki GN Goulielmos M Kalmanti 2011 The role of the methylenetetrahydrofolate reductase 677 and 1298 polymorphisms in cretan children with acute lymphoblastic leukemia Genet Test Mol Biomarkers 15 1-2 5 10 21117954 10.1089/gtmb.2010.0083 1:CAS:528:DC%2BC3MXht1yrsLo%3D
5. K Chatzidakis A Goulas F Athanassiadou-Piperopoulou L Fidani, et al. 2006 Methylenetetrahydrofolate reductase C677T polymorphism: association with risk for childhood acute lymphoblastic leukemia and response during the initial phase of chemotherapy in greek patients Pediatr Blood Cancer 47 2 147 151 16123993 10.1002/pbc.20574 (Pubitemid 44025246)
6. S Kishi J Griener C Cheng S Das, et al. 2003 Homocysteine, pharmacogenetics, and neurotoxicity in children with leukemia J Clin Oncol 21 16 3084 3091 12915598 10.1200/JCO.2003.07.056 1:CAS:528:DC%2BD2cXpsVWqtLg%3D (Pubitemid 46606289)
7. S Pakakasama K Kanchanakamhaeng S Kajanachumpol U Udomsubpayakul, et al. 2007 Genetic polymorphisms of folate metabolic enzymes and toxicities of high dose methotrexate in children with acute lymphoblastic leukemia Ann Hematol 86 8 609 611 17323057 10.1007/s00277-007-0274-x (Pubitemid 47018479)
8. L Huang WJ Tissing R de Jonge BD van Zelst, et al. 2008 Polymorphisms in folate-related genes: association with side effects of high-dose methotrexate in childhood acute lymphoblastic leukemia Leukemia 22 9 1798 1800 18368069 10.1038/leu.2008.66 1:CAS:528:DC%2BD1cXhtVyqu7zM
9. Lopez-Lopez E, Martin-Guerrero I, Ballesteros J, Piñan MA et al (2011) Polymorphisms of the SLCO1B1 gene predict methotrexate-related toxicity in childhood acute lymphoblastic leukemia. Pediatr Blood Cancer. doi: 10.1002/pbc.23074. (Published on line on 8 Mar 2011)
10. S Kishi C Cheng D French D Pei, et al. 2007 Ancestry and pharmacogenetics of antileukemic drug toxicity Blood 109 10 4151 4157 17264302 10.1182/blood-2006-10-054528 1:CAS:528:DC%2BD2sXls1anu74%3D (Pubitemid 46743376)
11. M Krajinovic E Lemieux-Blanchard S Chiasson M Primeau, et al. 2004 Role of polymorphisms in MTHFR and MTHFD1 genes in the outcome of childhood acute lymphoblastic leukemia Pharmacogenomics J 4 1 66 72 14647408 10.1038/sj.tpj.6500224 1:CAS:528:DC%2BD2cXltFanug%3D%3D (Pubitemid 38256607)
12. R Aplenc J Thompson P Han M La, et al. 2005 Methylenetetrahydrofolate reductase polymorphisms and therapy response in pediatric acute lymphoblastic leukemia Cancer Res 65 6 2482 2487 15781665 10.1158/0008-5472.CAN-04-2606 1:CAS:528:DC%2BD2MXisFGnsLg%3D (Pubitemid 40490161)
13. M Kantar B Kosova N Cetingul S Gumus, et al. 2009 Methylenetetrahydrofolate reductase C677T and A1298C gene polymorphisms and therapy-related toxicity in children treated for acute lymphoblastic leukemia and non-Hodgkin lymphoma Leuk Lymphoma 50 6 912 917 19391036 10.1080/10428190902893819 1:CAS:528:DC%2BD1MXntFChtr0%3D
14. PB van Kooten Niekerk K Schmiegelow H Schroeder 2008 Influence of methylene tetrahydrofolate reductase polymorphisms and coadministration of antimetabolites on toxicity after high dose methotrexate Eur J Haematol 81 5 391 398 18691257
15. I Costea A Moghrabi C Laverdiere A Graziani, et al. 2006 Folate cycle gene variants and chemotherapy toxicity in pediatric patients with acute lymphoblastic leukemia Haematologica 91 8 1113 1116 16870553 1:CAS:528:DC%2BD28XptVKhsL0%3D (Pubitemid 44204780)